Invega Sustenna (paliperidone palmitate extended-release 1-month injection) / J&J  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Invega Sustenna (paliperidone palmitate extended-release 1-month injection) / J&J
NCT01359293: Effects of Paliperidone Palmitate Versus Oral Antipsychotics on Clinical Outcomes and MRI Measures

Recruiting
N/A
120
US
paliperidone palmitate, Sustenna, oral antipsychotics
University of Iowa, Wishard Health Services
Schizophrenia, Schizophreniform
04/14
12/14

Download Options